News | January 20, 2022
Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
They will commercialize molnupiravir in the international markets
They will commercialize molnupiravir in the international markets
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The software enables real-time communication between patients, caregivers, physicians, and pharmacists and each cartridge in the device has a unique, traceable serial number registered to the patient
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
Tiger can no longer make an important biotin intermediate using a DSM patented process.
Godavari Biorefineries receives patent from CNIPA
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Bayer expects 2025 to be the most difficult year of its turnaround
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Subscribe To Our Newsletter & Stay Updated
